Uramustine

From WikiMD.org
Jump to navigation Jump to search

Uramustine

Uramustine (pronounced as yoo-rah-MUH-steen) is a type of chemotherapy drug used in the treatment of certain types of cancer, including lymphoma and leukemia. It is also known by its brand name, Uracil Mustard.

Etymology

The term "Uramustine" is derived from the combination of "Uracil", a component of RNA, and "Mustine", a type of alkylating agent used in chemotherapy.

Usage

Uramustine works by interfering with the growth of cancer cells, which eventually leads to their destruction. It is usually given by injection into a vein by a healthcare professional. The dosage is based on the patient's medical condition, body size, and response to therapy.

Side Effects

Common side effects of Uramustine include nausea, vomiting, and loss of appetite. More serious side effects can include low blood cell counts, infections, and bleeding. Patients should report any unusual symptoms to their healthcare provider immediately.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski